{"id":"https://openalex.org/W2095370280","doi":"https://doi.org/10.1046/j.1365-2133.2003.05728.x","title":"Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis","display_name":"Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis","alternate_titles":[],"publication_year":2004,"publication_date":"2004-03-01","ids":{"openalex":"https://openalex.org/W2095370280","doi":"https://doi.org/10.1046/j.1365-2133.2003.05728.x","mag":"2095370280","pmid":"https://pubmed.ncbi.nlm.nih.gov/15030339"},"language":"en","primary_location":{"id":"doi:10.1046/j.1365-2133.2003.05728.x","doi":"https://doi.org/10.1046/j.1365-2133.2003.05728.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2133.2003.05728.x","pdf_url":null,"source":{"id":"https://openalex.org/S45720283","display_name":"British Journal of Dermatology","issn_l":"0007-0963","issn":["0007-0963","1365-2133"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Dermatology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2095370280"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100603158","display_name":"Aditya K. Gupta","orcid":"https://orcid.org/0000-0002-8664-7723","observed_orcids":["https://orcid.org/0000-0002-8664-7723"]},"institutions":[{"id":"https://openalex.org/I1323843004","display_name":"Sunnybrook Health Science Centre","ror":"https://ror.org/03wefcv03","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I4210126549","display_name":"Mediprobe Research (Canada)","ror":"https://ror.org/02x3bf117","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210126549"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A.K. Gupta","raw_affiliation_strings":["Division of Dermatology, Department of Medicine, Sunnybrook and Women's College Health Science Center (Sunnybrook Site) and the University of Toronto, Toronto, Ontario, Canada. agupta@execulink.com","Mediprobe Laboratories, London, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Dermatology, Department of Medicine, Sunnybrook and Women's College Health Science Center (Sunnybrook Site) and the University of Toronto, Toronto, Ontario, Canada. agupta@execulink.com","institution_ids":["https://openalex.org/I1323843004","https://openalex.org/I185261750"]},{"raw_affiliation_string":"Mediprobe Laboratories, London, Ontario, Canada","institution_ids":["https://openalex.org/I4210126549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036994230","display_name":"Jennifer E Ryder","orcid":"https://orcid.org/0009-0003-2253-7036","observed_orcids":["https://orcid.org/0009-0003-2253-7036"]},"institutions":[{"id":"https://openalex.org/I4210126549","display_name":"Mediprobe Research (Canada)","ror":"https://ror.org/02x3bf117","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210126549"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J.E. Ryder","raw_affiliation_strings":["Mediprobe Laboratories, London, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mediprobe Laboratories, London, Ontario, Canada","institution_ids":["https://openalex.org/I4210126549"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072070089","display_name":"Andrew M. Johnson","orcid":"https://orcid.org/0000-0002-7269-3016","observed_orcids":["https://orcid.org/0000-0002-7269-3016"]},"institutions":[{"id":"https://openalex.org/I125749732","display_name":"Western University","ror":"https://ror.org/02grkyz14","country_code":"CA","type":"education","lineage":["https://openalex.org/I125749732"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A.M. Johnson","raw_affiliation_strings":["Faculty of Health Sciences, University of Western Ontario, London, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Health Sciences, University of Western Ontario, London, Ontario, Canada","institution_ids":["https://openalex.org/I125749732"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3731,"currency":"GBP","value_usd":4920},"apc_paid":null,"fwci":1.5108,"has_fulltext":false,"cited_by_count":174,"citation_normalized_percentile":{"value":0.78425656,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"150","issue":"3","first_page":"537","last_page":"544"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11253","display_name":"Nail Diseases and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11253","display_name":"Nail Diseases and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11037","display_name":"Fungal Infections and Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/onychomycosis","display_name":"onychomycosis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dermatophyte-onychomycosis","display_name":"dermatophyte onychomycosis","score":0.7990000247955322},{"id":"https://openalex.org/keywords/oral-antifungal-agents","display_name":"oral antifungal agents","score":0.8539999723434448},{"id":"https://openalex.org/keywords/terbinafine","display_name":"terbinafine","score":0.9959999918937683},{"id":"https://openalex.org/keywords/itraconazole","display_name":"itraconazole","score":0.9929999709129333},{"id":"https://openalex.org/keywords/fluconazole","display_name":"fluconazole","score":0.9900000095367432},{"id":"https://openalex.org/keywords/griseofulvin","display_name":"griseofulvin","score":1.0},{"id":"https://openalex.org/keywords/mycological-cure-rate","display_name":"mycological cure rate","score":0.8199999928474426},{"id":"https://openalex.org/keywords/clinical-cure-rate","display_name":"clinical cure rate","score":0.9340000152587891},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.45399999618530273},{"id":"https://openalex.org/keywords/open-label-study","display_name":"open-label study","score":0.39500001072883606},{"id":"https://openalex.org/keywords/nail-disorders","display_name":"nail disorders","score":0.382999986410141},{"id":"https://openalex.org/keywords/randomized-controlled-trials","display_name":"randomized controlled trials","score":0.4309999942779541}],"concepts":[{"id":"https://openalex.org/C2777071850","wikidata":"https://www.wikidata.org/wiki/Q411229","display_name":"Itraconazole","level":3,"score":0.92684006690979},{"id":"https://openalex.org/C2778236110","wikidata":"https://www.wikidata.org/wiki/Q415259","display_name":"Terbinafine","level":4,"score":0.9223121404647827},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8387072086334229},{"id":"https://openalex.org/C2780651595","wikidata":"https://www.wikidata.org/wiki/Q411478","display_name":"Fluconazole","level":3,"score":0.7464426755905151},{"id":"https://openalex.org/C2777220567","wikidata":"https://www.wikidata.org/wiki/Q613894","display_name":"Dermatophyte","level":2,"score":0.7202143669128418},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.6403182744979858},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5752401351928711},{"id":"https://openalex.org/C2779819575","wikidata":"https://www.wikidata.org/wiki/Q416096","display_name":"Griseofulvin","level":2,"score":0.5579977035522461},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5473809242248535},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.47078222036361694},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.45136287808418274},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.3749270439147949},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3314580023288727},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.31476861238479614}],"mesh":[{"descriptor_ui":"D000077291","descriptor_name":"Terbinafine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006118","descriptor_name":"Griseofulvin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009281","descriptor_name":"Naphthalenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014009","descriptor_name":"Onychomycosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015725","descriptor_name":"Fluconazole","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017964","descriptor_name":"Itraconazole","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017964","descriptor_name":"Itraconazole","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1365-2133.2003.05728.x","doi":"https://doi.org/10.1046/j.1365-2133.2003.05728.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2133.2003.05728.x","pdf_url":null,"source":{"id":"https://openalex.org/S45720283","display_name":"British Journal of Dermatology","issn_l":"0007-0963","issn":["0007-0963","1365-2133"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Dermatology","raw_type":"journal-article"},{"id":"pmid:15030339","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15030339","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The British journal of dermatology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":83,"referenced_works":["https://openalex.org/W62535563","https://openalex.org/W133083383","https://openalex.org/W289572164","https://openalex.org/W1501397114","https://openalex.org/W1501452339","https://openalex.org/W1967599717","https://openalex.org/W1969575982","https://openalex.org/W1970088989","https://openalex.org/W1972031953","https://openalex.org/W1973893693","https://openalex.org/W1979941741","https://openalex.org/W1984462605","https://openalex.org/W1987389138","https://openalex.org/W1987633267","https://openalex.org/W1993188180","https://openalex.org/W1993820120","https://openalex.org/W2003293898","https://openalex.org/W2003440586","https://openalex.org/W2004466207","https://openalex.org/W2007274339","https://openalex.org/W2008993478","https://openalex.org/W2011242106","https://openalex.org/W2015975523","https://openalex.org/W2017099680","https://openalex.org/W2017361974","https://openalex.org/W2018964789","https://openalex.org/W2021665274","https://openalex.org/W2026020458","https://openalex.org/W2030208825","https://openalex.org/W2031188384","https://openalex.org/W2036214634","https://openalex.org/W2037854508","https://openalex.org/W2040227828","https://openalex.org/W2041653388","https://openalex.org/W2042250295","https://openalex.org/W2044371737","https://openalex.org/W2049731264","https://openalex.org/W2050494237","https://openalex.org/W2058291465","https://openalex.org/W2064806323","https://openalex.org/W2066250474","https://openalex.org/W2069871493","https://openalex.org/W2071343620","https://openalex.org/W2078123694","https://openalex.org/W2082100232","https://openalex.org/W2086012496","https://openalex.org/W2088822653","https://openalex.org/W2090642049","https://openalex.org/W2090861008","https://openalex.org/W2092076778","https://openalex.org/W2094644621","https://openalex.org/W2095686961","https://openalex.org/W2099466410","https://openalex.org/W2106090344","https://openalex.org/W2106242890","https://openalex.org/W2106488529","https://openalex.org/W2107328434","https://openalex.org/W2112046867","https://openalex.org/W2112394851","https://openalex.org/W2117618454","https://openalex.org/W2122845449","https://openalex.org/W2126113825","https://openalex.org/W2130784837","https://openalex.org/W2132109577","https://openalex.org/W2134338262","https://openalex.org/W2143292648","https://openalex.org/W2149876449","https://openalex.org/W2164794489","https://openalex.org/W2166412821","https://openalex.org/W2167684373","https://openalex.org/W2169904859","https://openalex.org/W2234692523","https://openalex.org/W2239862275","https://openalex.org/W2410774798","https://openalex.org/W2412932692","https://openalex.org/W2416636089","https://openalex.org/W2436303970","https://openalex.org/W4211023434","https://openalex.org/W4232633614","https://openalex.org/W4248456141","https://openalex.org/W4285719527","https://openalex.org/W4417057909","https://openalex.org/W7214203299"],"related_works":["https://openalex.org/W1990447927","https://openalex.org/W2004466207","https://openalex.org/W2003906894","https://openalex.org/W2990215547","https://openalex.org/W2369123537","https://openalex.org/W2302622832","https://openalex.org/W2040634205","https://openalex.org/W1980037467","https://openalex.org/W2945981162","https://openalex.org/W1967599717"],"abstract_inverted_index":{"BACKGROUND:":[0],"Onychomycosis":[1],"is":[2,8,196],"a":[3,16,125,150],"common":[4,22],"nail":[5],"disease":[6],"that":[7,417],"often":[9],"chronic,":[10],"difficult":[11],"to":[12,18,49,92,153,160,187,213,237,261,284,308],"eradicate,":[13],"and":[14,32,78,112,132,297,383,444],"has":[15,59],"tendency":[17],"recur.":[19],"The":[20,321,408,432],"most":[21,162],"oral":[23,103],"therapies":[24],"for":[25,44,66,95,114,192,414],"dermatophyte":[26,116],"toenail":[27,117],"onychomycosis":[28],"include":[29],"terbinafine,":[30,106,203,336],"itraconazole":[31,107,226,250,359],"fluconazole.":[33],"OBJECTIVES:":[34],"A":[35],"cumulative":[36,138,190,322,409],"meta-analysis":[37,123,410],"of":[38,55,75,82,101,156,179,325,411,435],"the":[39,52,56,63,71,99,102,137,154,161,171,175,184,188,426],"randomized":[40],"controlled":[41],"trials":[42],"(RCTs)":[43],"antimycotic":[45],"agents":[46,105],"was":[47],"performed":[48],"determine":[50,136],"whether":[51],"pooled":[53,144],"estimate":[54],"cure":[57,181,327,412,448],"rates":[58,81,182,328,413,428,434],"remained":[60,430],"consistent":[61],"over":[62,418],"years.":[64],"Furthermore,":[65],"each":[67,193],"agent":[68],"we":[69],"compared":[70,441],"overall":[72,189],"meta-analytical":[73,139,323],"average":[74,324],"both":[76],"mycological":[77,180,326],"clinical":[79],"response":[80],"RCTs":[83,174,331,415,422,443],"vs.":[84,332,346,370,394],"open":[85,333,436],"studies.":[86],"METHODS:":[87],"We":[88],"searched":[89],"MEDLINE":[90],"(1966":[91],"November":[93],"2002)":[94],"relevant":[96],"studies":[97,141,168,334,437],"evaluating":[98],"efficacy":[100,178,427,433],"antifungal":[104],"(pulse":[108],"or":[109],"continuous),":[110],"fluconazole":[111],"griseofulvin":[113],"treating":[115],"onychomycosis.":[118],"Studies":[119],"included":[120,169],"in":[121,170,177],"this":[122],"required":[124],"standard":[126],"accepted":[127],"dosage":[128],"regimen,":[129],"treatment":[130],"duration":[131],"follow-up":[133],"period.":[134],"To":[135],"average,":[140],"were":[142,166],"sequentially":[143],"by":[145],"adding":[146],"one":[147],"study":[148],"at":[149],"time":[151],"according":[152],"date":[155],"publication":[157],"(i.e.":[158],"earliest":[159],"recent).":[163],"RESULTS:":[164],"There":[165],"36":[167],"analyses.":[172],"For":[173],"change":[176],"from":[183],"first":[185],"trial":[186],"meta-average":[191],"drug":[194],"comparator":[195],"as":[197,420],"follows":[198],"(with":[199],"95%":[200],"confidence":[201],"interval):":[202],"78":[204],"+/-":[205,215,229,239,253,263,276,286,300,310,338,348,362,372,386,396],"6%":[206,277,311],"(n":[207,217,231,241,255,265,278,288,302,312,340,350,364,374,388,398],"=":[208,218,224,232,242,248,256,266,272,279,289,295,303,313,319,341,351,357,365,375,381,389,399,405],"2":[209,304,352],"studies,":[210,220,244,268,291,305,315,343,353,367,377,391,401],"79":[211,395],"patients)":[212,222,236,246,260,270,283,293,307,317,345,355,369,379,393,403],"76":[214,337],"3%":[216,339,397],"18":[219,342],"993":[221,344],"(P":[223,247,271,294,318,356,380,404],"0.68);":[225],"pulse,":[227,360],"75":[228],"10%":[230],"1":[233,257,280],"study,":[234,258,281],"20":[235],"63":[238,252,361],"7%":[240,363],"6":[243,366],"318":[245,368],"0.25);":[249],"continuous,":[251],"5%":[254,264,287,387],"84":[259,371],"59":[262],"7":[267],"1131":[269],"0.47);":[273],"fluconazole,":[274,384],"53":[275],"72":[282],"48":[285,385],"3":[290,314,376,390,400],"131":[292,392],"0.50);":[296],"griseofulvin,":[298],"55":[299],"8%":[301],"109":[306],"60":[309],"167":[316],"0.41).":[320],"when":[329],"comparing":[330],"was:":[335],"83":[347],"12%":[349],"391":[354],"0.0028);":[358],"9%":[373],"194":[378],"0.0001);":[382],"208":[402],"0.0001).":[406],"CONCLUSIONS:":[407],"suggests":[416],"time,":[419],"new":[421],"have":[423,429],"been":[424],"conducted,":[425],"consistent.":[431],"are":[438],"substantially":[439],"higher":[440],"with":[442],"may":[445],"therefore":[446],"overestimate":[447],"rates.":[449]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2095370280","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":13},{"year":2014,"cited_by_count":16},{"year":2013,"cited_by_count":13},{"year":2012,"cited_by_count":11}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
